Preoperative Hyperthermia in Major Abdominal Surgery Patients
NCT ID: NCT00876954
Last Updated: 2016-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
20 participants
INTERVENTIONAL
2009-04-30
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perioperative Normothermia: Temperature and Prewarming Methods
NCT04011462
Composite Warming Strategy Reduces Intraoperative Hypothermia in Open Hepatectomy for Liver Cancer
NCT06766773
The Use of Thermal Suits as Preventing Hypothermia During Surgery
NCT01571544
Impact of Expanded Peri Operative Warming
NCT01649596
Local CO2 Increases Core and Wound Temperature
NCT01213628
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Warming without increase in core temperature
Normothermia
Warming without increase in core temperature
Hyperthermia
Hyperthermia for 2,5 hours (39 °C core temperature)
Hyperthermia
Core hyperthermia (39 °C) for 2,5 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Normothermia
Warming without increase in core temperature
Hyperthermia
Core hyperthermia (39 °C) for 2,5 hours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Open abdominal, curative cancer surgery \> 2 h
Exclusion Criteria
* Chronic cortisone treatment
* Ongoing chemotherapy
* Acute infections, septic surgery
* Palliative surgery (e.g. debulking only)
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Braun Stiftung
UNKNOWN
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Oliver Kimberger
Assoc.Prof.PD Dr. MSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oliver Kimberger, M.D.
Role: PRINCIPAL_INVESTIGATOR
Medical University of Vienna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oliver Kimberger M.D.
Vienna, Vienna, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PreopHypertherm1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.